| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021935 |
| Receipt No. | R000025224 |
| Official scientific title of the study | Retrospective study on effectiveness of combination drugs for hypertension - Consideration on blood-pressure control before and after switch from concomitant use of single drugs to combination drug - |
| Date of disclosure of the study information | 2016/04/16 |
| Last modified on | 2017/05/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Retrospective study on effectiveness of combination drugs for hypertension
- Consideration on blood-pressure control before and after switch from concomitant use of single drugs to combination drug - |
|
| Title of the study (Brief title) | Retrospective study on effectiveness of combination drugs for hypertension | |
| Region |
|
|
| Condition | ||
| Condition | hypertension | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Recently, a lot of combination drugs have been approved in Japan, which included more than 2 active ingredients. It is considered that combination drug contributes improvement of patient compliance, but there is no objective data. This study is to provide some evidence for insights on effectiveness of combination drugs through retrospective evaluation for blood-pressure control on patients with hypertension before and after switching from concomitant use of single drugs to combination drug. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Change of blood-pressure before and after switching concomitant use of single drugs to combination drug |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients who are treated with concomitant use of single hypertension drugs for 6 months or more
2)Patients who are treated with hypertension combination drug for 6 months or more, which includes same active ingredients treated in the previous concomitant use of single drugs |
|||
| Key exclusion criteria | None | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Takao Aoyama |
| Organization | Tokyo University of Science |
| Division name | Faculty of Pharmaceutical Sciences |
| Address | 2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan |
| TEL | 04-7121-4134 |
| t-aoyama@rs.noda.tus.ac.jp | |
| Public contact | |
| Name of contact person | Takao Aoyama |
| Organization | Tokyo University of Science |
| Division name | Faculty of Pharmaceutical Sciences |
| Address | 2641 Yamazaki Noda City, Chiba Pref., 278-8510, Japan |
| TEL | 04-7121-4134 |
| Homepage URL | |
| t-aoyama@rs.noda.tus.ac.jp | |
| Sponsor | |
| Institute | Laboratory of pharmacotherapeutics, Tokyo University of Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kan-Etsu hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Ongoing data analysis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025224 |